AbCellera Biologics Inc. (ABCL)
NASDAQ·Healthcare·Biotechnology
$5.68
+11.49%
Mkt Cap $1.60B
Analyst Ratings
No recent rating data.
Price Target (8 analysts)
$7.00
Range $7.00 – $7.00
Implied Upside
+23.3%
Consensus $7.00 vs current $5.68
NASDAQ·Healthcare·Biotechnology
$5.68
+11.49%
Mkt Cap $1.60B
No recent rating data.
Price Target (8 analysts)
$7.00
Range $7.00 – $7.00
+23.3%
Consensus $7.00 vs current $5.68